Oxidant-protease interaction in the lung: Prospects for antioxidant therapy

Chest

Volumn 110, Issue 6 SUPPL., 1996, Pages 267S-272S

  Buhl, Roland ^a   Meyer, Andreas ^b   Vogelmeier, Claus ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

antioxidants; emphysema; oxidants; proteases; 1 antitrypsin

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT; PROTEINASE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; DRUG RESEARCH; DRUG SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030465016     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Hubbard RC, Crystal RG. Antiproteases and antioxidants: strategies for the pharmacologic prevention of lung destruction. Respiration 1986; 50(suppl 1):56-73
2. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76
3. Gadek JE, Pacht ER. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 1990; 168(suppl):30-42
4. Crystal RG, Bast A, Roshan-Ali Y, eds. Oxidants and antioxidants: pathophysiological determinants and therapeutic agents. Am J Med 1991; 91(suppl 3C):1S-145S
5. Lucey EC, Stone PJ, Snider GL. Consequences of proteolytic injury. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1789-1801
6. Tetley TD. Proteinase imbalance: its role in lung disease. Thorax 1993; 48:560-65
7. Buhl R, Stahl E, Meier-Sydow J. In vivo assessment of pulmonary oxidant damage: the role of bronchoalveolar lavage. Monaldi Arch Chest Dis 1994; 49(suppl 1):1-8
8. Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988; 84:37S-42S
9. Hubbard RC, Brantly ML, Crystal RG. Proteases. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1763-73
10. Crystal RG. α1-Antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy. J Clin Invest 1990; 85:1343-52
11. Vogelmeier C, Hubbard RC, Fells GA, et al. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991; 87:482-88
12. Hubbard RC, Crystal RG. Antiproteases. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1775-87
13. Maier KL, Leuschel L, Costabel U. Increased oxidized methionine residues in BAL fluid proteins in acute or chronic bronchitis. Eur Respir J 1992; 5:651-58
14. McElvaney NG, Nakamura H, Birrer P, et al. Modulation of airway inflammation in cystic fibrosis: in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992; 90:1296-1301
15. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339:466-69
16. Hubbard RC, Ogushi F, Fells GA, et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of α1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80:1289-95
17. Wallaert B, Gressier B, Marquette CH, et al. Inactivation of α1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema. Am Rev Respir Dis 1993; 147:1537-43
18. Schraufstätter IU, Cochrane CG. Oxidants: types, sources, and mechanisms of injury. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1803-10
19. Church DF, Pryor WA. The oxidative stress placed on the lung by cigarette smoke. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1975-80
20. Warren JS, Johnson KJ, Ward PA. Consequences of oxidant injury. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1829-38
21. Theron A, Anderson R. Investigation of the protective effects of the antioxidants ascorbate, cysteine, and dapsone on the phagocyte-mediated oxidative inactivation of human alpha-1-protease inhibitor in vitro. Am Rev Respir Dis 1985; 132:1049-54
22. Borregaard N, Jensen HS, Bjerrum OW. Prevention of tissue damage: inhibition of myeloperoxidase mediated inactivation of α1-proteinase inhibitor by N-acetylcysteine, glutathione, and methionine. Agents Actions 1987; 22:255-60
23. Aruoma OI, Halliwell B, Hoey BM, et al. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6:593-97
24. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140:531-54
25. Heffner JE, Repine JE. Antioxidants and the lung. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1811-20
26. Cantin AM, Fells GA, Hubbard RC, et al. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 1990; 86:962-71
27. Davis WB, Pacht ER. Extracellular antioxidant defenses. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 1821-28
28. Murderly JL, Samet JM. General environment: antioxidant macromolecules in the epithelial lining fluid of the normal human respiratory tract. In: Crystal RG, West JB, eds. The lung: scientific foundations. New York: Raven Press, 1991; 962-71
29. Cantin AM, North SL, Hubbard RC, et al. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-57
30. Cantin AM, Bégin RO. Glutathione and inflammatory disorders of the lung. Lung 1991; 169:123-38
31. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 1992; 44:1905-15
32. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 2:1294-98
33. Hubbard RC, Casolaro MA, Mitchell M, et al. Fate of aerosolized recombinant DNA-produced α1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance. Proc Natl Acad Sci USA 1989; 86:680-84
34. Buhl R, Vogelmeier C, Crittenden M, et al. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci USA 1990; 87:4603-07
35. Cantin AM, North SL, Fells GA, et al. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79:1665-73
36. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989; 139: 370-72
37. Strausz J, MüUer-Quernheim J, Steppling H, et al. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1990; 141:124-28
38. Borok Z, Buhl R, Grimes GJ, et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338:215-16
39. Buhl R, Jaffe HA, Holroyd KJ, et al. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993; 150:1019-28
40. Buhl R. Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals. Chem Biol Interact 1994; 91:147-58
41. Meyer A, Buhl R, Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 1994; 7:431-36
42. Maier K, Leuschel L, Costabel U. Increased levels of oxidized methionine residues in BAL fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 143: 271-74
43. Holroyd KJ, Buhl R, Borok Z, et al. Correction of the glutathione deficiency in the lower respiratory tract of HIV-seropositive individuals by glutathione aerosol therapy. Thorax 1993; 48:985-89
44. Roum JH, Buhl R, McElvaney NG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993; 75:2419-24
45. Pacht ER, Timerman AP, Lykens MG, et al. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100:1397-1403
46. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148:1174-78
47. Suter PM, Domenighetti G, Schaller M-D, et al. N-acetylcysteine enhances recovery from acute lung injury in man. Chest 1994; 105:190-94
48. Thompson AB, Daughton D, Robbins RA, et al. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-37
49. Thompson AB, Heires A, Bohling T, et al. The antioxidant activity of bronchoalveolar lavage fluid is diminished in association with chronic bronchitis. Am Rev Respir Dis 1991; 143:A742
50. Pozzi E, De Rose V, Rennard SI, et al. Guidelines and recommendation for the clinical use of bronchoalveolar lavage in chronic bronchitis and emphysema. Eur Respir Rev 1992; 2:121-24
51. ++ superoxide dismutase. Chest 1993; 104:811-15
52. Vogelmeier C, Buhl R, Hoyt RF, et al. Aerosolization of recombinant secretory leukoprotease inhibitor to augment anti-neutrophil elastase protection of the pulmonary epithelium. J Appl Physiol 1990; 69:1843-48
53. Gillissen A, Birrer P, McElvaney NG, et al. Recombinant secretory leukoprotease inhibitor augments glutathione levels in respiratory epithelial lining fluid. J Appl Physiol 1993; 75:825-32
54. Erzurum SC, Chu C-S, Danel C, et al. Human alveolar macrophages express antioxidant genes at a higher level than respiratory epithelial cells in vivo. Am Rev Respir Dis 1992; 145:A713
55. Hass MA, Iqbal J, Clerch LB, et al. Rat lung Cu,Zn superoxide dismutase: isolation and sequence of a full-length cDNA and studies of enzyme induction. J Clin Invest 1989; 83:1241-46
56. Erzurum SC, Lemarchand P, Rosenfeld MA, et al. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acid Res 1993; 21:1607-12
57. Rosenfeld M, Siegfried W, Yoshimura K, et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252:431-34